Patient who performed Maze operation for atrial fibrillation
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: patients from whom informed consent was obtained
Exclusion criteria
Exclusion criteria: Doctor's decision not to register to this regimen
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ncidence of postoperative atrial fibrillation hyaluronan, KL-6, ANP, angiotensin-II | — |
Secondary
| Measure | Time frame |
|---|---|
| Age LA diameter BNP Duration of the disorder for Af | — |
Countries
Japan
Contacts
Nihon University school of medicine Department of Cardiovascular Surgery